1 Introduction Cancer persists as the second leading cause of global mortality, with epidemiological projections estimating 19.97 million new cases and 9.74 million deaths in 2024 ( Nutraceuticals have emerged as compelling candidates in translational oncology, leveraging their dual capacity to potentiate anticancer effects while mitigating treatment-related toxicity ( 2 O 2 )-mediated responses, including adenosine triphosphate (ATP) depletion, iron-regulated epigenetic reprogramming, anti-apoptotic protein B cell lymphoma 2 (Bcl-2) inhibition, Bax (Bcl-2 associated X protein, a well-known pro-apoptotic mediator) activation, mitochondrial hyperpolarization induction, the cleavage of poly (ADP-ribose) polymerase (PARP, a known apoptotic indicator) and caspases, mainly caspases 3 and 7 as well as targeting hypoxia-inducible factor-1 ( HIF- ) ( The therapeutic application of VC in oncology has been plagued by persistent controversies, particularly regarding dose-response relationships and administration route efficacy

Isolated mitochondria were washed twice with basic STE buffer (without 0.1% fatty acidfree BSA), resuspended in basic STE buffer and protein concentration of mitochondrial proteins was determined by the bicinchoninic acid (BCA) assay using BSA as a standard
Skeletal Muscle
Exploring Keratosis Pilaris: Common Causes and Symptoms Keratosis Pilaris, which can also be called "chicken skin", is a harmless skin condition that affects millions of people worldwide
It has been used widely by clinicians as a reliable source to treat vitamin B12 deficiency